Acupuncture on Post-Stroke Overactive Bladder

Overview

This study evaluates the effect of acupuncture on post-stroke overactive bladder symptoms. Participants will be put into groups randomly and compared. There are two groups: traditional acupuncture and usual care. The ratio of group allocation is 1:1.

Full Title of Study: “Acupuncture on Post-Stroke Overactive Bladder: A Randomized Controlled Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: August 2018

Detailed Description

Current practice in management of OAB is quite limited. Acupuncture, which is a major treatment modality of traditional Chinese medicine, has also claimed to have favourable therapeutic effect on OAB. Previous study found that acupuncture at the BL-33 point was effective for controlling the overactive bladder. Although acupuncture has been shown to be effective in treating OAB, there has been no randomized controlled trial examining the efficacy of acupuncture on patients with post-stroke. Given the high incidence of OAB in post-stroke patients, potentially effective alternative treatments should be investigated.

Interventions

  • Other: Traditional Acupuncture
    • Treatment is based on the traditional Chinese medicine theory for treating overactive bladder. Qi-transforming function of bladder is regulated by experienced Chinese medicine practitioner.
  • Other: Usual Care
    • Patients will receive conventional rehabilitation as usual, including standard physiotherapy, bladder training and general advise of fluid intake.

Arms, Groups and Cohorts

  • Experimental: Traditional Acupuncture
    • Acupoints which are empirical for treating OAB in terms of Traditional Chinese medicine theory are used (in the sequence of scalp reproduction area and motor area of the unaffected side, RN3, bilateral BL32, BL33, BL28, BL39). And Ear point urinary bladder, and Ear point uterus will be treated after removal of needles. Needles will be left for 30 minutes and then removed. Subjects will be treated with acupuncture 2 times per week for the first 2 weeks and 1 per week for the 3rd and 4th week.
  • Other: Usual Care
    • Patients will receive conventional rehabilitation as usual, including standard physiotherapy, bladder training and general advise of fluid intake.

Clinical Trial Outcome Measures

Primary Measures

  • Overactive Bladder Symptom Scale (OABSS)
    • Time Frame: 1-week posttreatment
    • four item questionnaire quantifies overactive bladder symptoms in a single score

Secondary Measures

  • Number of incontinent episodes measured by bladder diary
    • Time Frame: 1-week posttreatment, 4-week posttreatment
    • Record the frequency of day and night time voiding and incontinence episodes over 3 day periods
  • Stroke Specific Quality of Life Scale (SS-QoLS)
    • Time Frame: 1-week posttreatment, 4-week posttreatment
    • 12 items questionnaire consists of physical and psychosocial subscales: amount of help required completing a task, trouble experienced performing a task and functioning.
  • Medication measured by bladder diary
    • Time Frame: 1-week posttreatment, 4-week posttreatment
    • number of patients requested medication for OAB from bladder diary.

Participating in This Clinical Trial

Inclusion Criteria

1. Chinese aged 18 or above 2. Patient suffering from first ever stroke or recurrent stroke with no urinary symptom in previous episode(s); 3. Patient with classic symptoms, i.e. urgency, urinary frequency or urge incontinence and Overactive Bladder Symptom Score (OABSS) score ≥3 and the urgency item rated as at least 2-point; 4. Not taking any medication for OAB 5. Able to communicate 6. No current acupuncture or transcutaneous electrical nerve stimulation treatment Exclusion Criteria:

1. Urinary retention with post-void urinary volume > 100ml; 2. Current urinary tract infection; 3. Preexisting history of OAB or bladder outlet obstruction or underactive bladder; 4. Significant cognitive impairment with MMSE < or =19; 5. Coexisting Alzheimer's disease, Parkinson's disease, spinal cord disorder or progressive neurological disease such as multiple sclerosis; 6. Active skin lesion or open wound over the needle placement areas; 7. Having valvular heart defects, severe cardiac diseases, or bleeding disorders, 8. Being fitted with any implanted electrical device such as pacemaker, defibrillator, or brain stimulation; 9. Pregnant; 10. Malignancies at the sites of selected acupoints; 11. Receiving acupuncture treatment 1 month before baseline.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • The University of Hong Kong
  • Provider of Information About this Clinical Study
    • Principal Investigator: Dr. Haiyong Chen, Research Assistant Professor – The University of Hong Kong
  • Overall Official(s)
    • Wing Fai Yeung, BCM, PhD, Principal Investigator, The University of Hong Kong

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.